
|Articles|January 1, 2003
Anti-aging's exciting new cosmeceuticals
Author(s)Suzette Hill
Virginia Beach, Va. - Describing idebenone as the "most potent" antioxidant he's researched to date, David H. McDaniel, M.D., believes the synthetic analog of ubiquinone (coenzyme Q10) represents the first of a new class of cosmeceuticals.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Phase 3 Data Position Zasocitinib as a Potential New Oral Option for Psoriasis
2
Highlighting Major Breakthroughs for Atopic Dermatitis and Psoriasis in 2025
3
First-in-Class Topical GT20029 Demonstrates Promising Phase 2 Efficacy and Tolerability for AGA
4
Topicals Demonstrate Targeted Control Across 3 Distinct Atopic Dermatitis Cases
5

















